NeuroServo: Funding, Investors & Team (Oct 2026)
NeuroServo has introduced VEEGix, an innovation in the EEG field for medical purposes. VEEGix is a compact prefrontal EEG that is specifically created for use in critical care settings during emergencies. Traditional EEGs require an EEG specialist to set up the equipment and a neurologist to interpret the results, which can take up to four hours. Conversely, VEEGix is intended to be installed by nurses and provide an easy-to-understand brain status report in under a minute. Although VEEGix is not meant to replace a complete traditional EEG, it is designed to be used as an emergency EEG when time is a crucial factor, as some conditions have less than an hour before they cause permanent brain damage, and as a monitoring device for sedated patients.
NeuroServo has raised $1.7M across 3 funding rounds on record, the most recent a Seed of $1.7M announced in Jun 2023.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
NeuroServo Company Profile and Key Stats
Latest funding round on record: Jun 2023.
NeuroServo Funding Rounds
2 of 3 rounds were announced without a disclosed amount and are excluded from the total.
NeuroServo announced a Seed in Aug 2022; the amount was not disclosed.
8 months later, an undisclosed round was announced in Apr 2023 with no disclosed amount.
2 months later, a Seed of $1.7M was announced in Jun 2023.
NeuroServo Founders and Leadership Team
Contact details for the NeuroServo team: 1 of 2 have an email address on file.
Start 14-day free trial →NeuroServo Funding Compared to Other Health Care Startups
NeuroServo's latest round of $1.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeuroServo in Health Care and Montréal
Companies Similar to NeuroServo
Personalized, at-home fertility kits to optimize outcomes
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
NeuroServo Funding FAQs
What does NeuroServo do?
NeuroServo has introduced VEEGix, an innovation in the EEG field for medical purposes. VEEGix is a compact prefrontal EEG that is specifically created for use in critical care settings during emergencies. Traditional EEGs require an EEG specialist to set up the equipment and a neurologist to interpret the results, which can take up to four hours. Conversely, VEEGix is intended to be installed by nurses and provide an easy-to-understand brain status report in under a minute. Although VEEGix is not meant to replace a complete traditional EEG, it is designed to be used as an emergency EEG when time is a crucial factor, as some conditions have less than an hour before they cause permanent brain damage, and as a monitoring device for sedated patients.
How much funding has NeuroServo raised?
NeuroServo has raised $1.7M across 3 rounds on record. The most recent is a Seed of $1.7M announced in Jun 2023.
When did NeuroServo last raise funding?
NeuroServo's most recent funding round on record is a Seed of $1.7M, announced in Jun 2023.
Who founded NeuroServo?
FundedIQ lists Jerome Arnaud (Founder), Nicolas Tremblay (Founder) at NeuroServo.
Where is NeuroServo headquartered?
NeuroServo is based in Montréal, Quebec, Canada.
How many employees does NeuroServo have?
NeuroServo is in the 1-10 employee band.
How does NeuroServo's funding compare to other Health Care startups?
NeuroServo's latest round of $1.7M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's NeuroServo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroServo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.